title: The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancer.
authors.affiliation: Division of Urology, University of Colorado Health Sciences Center, Denver.
authors.forename: E D
authors.initials: ED
authors.lastname: Crawford
authors.forename: J M
authors.initials: JM
authors.lastname: Kozlowski
authors.forename: F M
authors.initials: FM
authors.lastname: Debruyne
authors.forename: W R
authors.initials: WR
authors.lastname: Fair
authors.forename: C J
authors.initials: CJ
authors.lastname: Logothetis
authors.forename: C
authors.initials: C
authors.lastname: Balmer
authors.forename: R G
authors.initials: RG
authors.lastname: Robinson
authors.forename: A T
authors.initials: AT
authors.lastname: Porter
authors.forename: D
authors.initials: D
authors.lastname: Kirk
mesh_terms: D000368:Aged; D001859:Bone Neoplasms / Q000150:complications / Q000556:secondary*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009919:Orchiectomy; D010148:Intractable Pain / Q000209:etiology / Q000532:radiotherapy*; D010166:Palliative Care / Q000379:methods*; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000628:therapy; D013326:Strontium Radioisotopes / Q000627:therapeutic use*; D017211:Treatment Failure
chemical_list: D006728:Hormones; D013326:Strontium Radioisotopes